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Aim:Androgen excess predisposes the organism to developmetabolic–endocrine and reproductive dysfunctions,
among them the development of a phenotype resembling that of human Polycystic Ovary Syndrome (PCOS).
Methods:We analyzed the impact of a single neonatal (5 day-old) testosterone propionate (TP; s.c. 1.25 mg/fe-
male pup) dose on: a) several metabolic–endocrine activities and b) ovarian steroidogenic and granulosa cell
(GC) functions and also follicular population in juvenile and adult TP and control (CT) rats.
Key ﬁndings: Compared to CT rats, TP animals were characterized by: a) accelerated growth, hyperadiposity and
hyperleptinemia, b) very early (pre-weaning age) vaginal opening, c) hyperinsulinemia in adult life,
d) dysfunctional ovarian steroidogenesis, e) conserved GC functionality in both juveniles (in vitro) and adults
(in vivo), and f) estrous cycles arrested at estrus. Finally, histological studies of the ovaries indicated that in TP
(vs. CT) rats: i) primary and antral follicle frequencies were 3- and 15-fold higher and lower, respectively, in ju-
veniles and ii) secondary and atretic follicle frequencies were 3- and 5-fold lower and higher, respectively, in
adults. Large cystic images without corpus luteum were observed in the ovaries from adult TP rats only.
Signiﬁcance: Our results strongly suggest that transient neonatal hyperandrogenemia induced early
misprogramming of metabolic–endocrine and ovarian (steroidogenesis/folliculogenesis) functions. Conversely,
TP rats preserved their ovary GC endocrine function. Our results further support the high risk of developing ovar-
ian hyperstimulation syndrome for infertile womenwith transient/chronic hyperandrogenemia (PCOS) subject-
ed to assisted reproductive technologies.© 2015 Elsevier Inc. All rights reserved.1. Introduction
A very common cause of menstrual disturbances, chronic ano-
vulation and hyperandrogenism in pre-menopausal women is Polycys-
tic Ovary Syndrome (PCOS) [9,10]. Although a very large population of
women at reproductive age is affected by PCOS, diagnosis of this syn-
drome is still difﬁcult for physicians [11]. Insulin resistance, with or
without compensatory hyperinsulinemia, is frequently associated with
PCOS [3,11,13]. Moreover, clinical and experimental studies suggest in-
teraction between insulin and sex hormones in healthy subjects [2]. We
previously found that androgenization in normal female rats, at either
neonatal [1,19] or early post-pubertal [20] age, developed impaired in-
sulin sensitivity in adulthood. We also observed a severe hypothalam-
ic–pituitary–ovary (HPO) axis dysfunction in neonatally androgenized
adult female rats. Indeed, on reaching adulthood, rats developed an al-
tered pulsatile rhythm of gonadotropin secretion (e.g. decreased aver-
age mean values, decreased FSH peak amplitude values and increasedArgentina.LH:FSH ratio) and impaired in vivo LHRH-stimulated LH–FSH release
[23]. These abnormalities have been ascribed to a neonatal hypothalam-
ic effect of transient peripheral androgen excess (hypothalamic
androgenization), later resulting in infertile individuals [4].
Regarding the relation between early hyperandrogenemia and adi-
pose tissue function, we previously established that 100 day-old neona-
tal androgenized female rats are heavier and display greater adiposity,
hyperleptinemia, impaired peripheral insulin sensitivity, and increased
risk of developing dyslipidemia and cardiovascular risk [1]. In this re-
gard, although physiological peripheral leptin levels are needed for nor-
mal HPO axis function [21], chronic high plasma leptin concentrations
(leptin resistance) are critical for consequent ovary dysfunction (e.g.
anovulation) [32]. Nevertheless, it is accepted that follicle oocytes and,
granulosa and theca cells express androgen receptor, a gonadotropin-
regulated element [28] that must be ﬁne-tuned by appropriate
androgen stimulation to assure normal follicle development and o-
vulation [28]. Tyndall et al. [24] recently investigated the effects of
fetal and post-natal treatment with multiple high doses of androgen
in female rats. These authors found that fetal injury (transient
hyperandrogenemia in dams) failed to alter rat ovary folliculogenesis
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ministered at any post-natal age (before 25 days of age) induced an in-
complete PCOS rat phenotype [24].
In the present study, we aimed to investigate in the female rat
whether a single, early post-natal (day 5), testosterone propionate
(TP; 1.25mg/pup, s.c.) treatmentwould be able to change the program-
ming of metabolic–endocrine and reproductive functions. With this
aim, we evaluated: a) several peripheral biomarkers and b) ovarian
functionality (some steps of the steroidogenic process, folliculogenesis
and granulosa cell endocrine function) in TP and their littermate control
(CT) female rats when reaching juvenile and adult ages.
2. Materials and methods
2.1. Experimental animals
Weused the classical Barraclough's animalmodel [4], previously val-
idated in our laboratory [1]. Brieﬂy, 5 day-old Sprague–Dawley female
rat pups (10.65 ± 0.27 g BW; n = 80) were s.c. injected with 50 μL of
sterile corn oil either alone (CT group; n = 35/40) or containing
1.25 mg of TP (Organon Lab., Argentina, n = 35/40). The vaginal open-
ing was checked between 7 and 45 days of age. After weaning (21 days
of age), rats were housed individually. Body weight (BW) and food in-
take were recorded daily (between 07:30 and 08:30 h) up to the corre-
sponding experimental day (juvenile and adult ages, 30 and 60 days of
age, respectively). Animals were kept in a light- (lights on from 07:00 to
19:00 h) and temperature (22 °C)-controlled room throughout the ex-
periment. Rats were fed a commercial rat diet (Ganave Lab.,
Argentina) and provided with tap water ad libitum throughout the en-
tire housing period. The experiments were approved by our Institution-
al Animal Care Committee; international regulations concerning ethical
use of animals were strictly followed.
2.2. Experimental designs
Experiment 1. Rats from both groups were killed (between 08:00 and
09:00 h) at 30 days of age (juvenile age) in non-fasting
conditions. Immediately after killing trunk blood was
collected (into EDTA 10%–sodiumﬂuoride coated plastic
tubes), parametrial adipose tissue (PMAT) and ovaries
were dissected, weighed, and either used for (see
below) histological analyses or kept frozen (at−80 °C)
until further assays.
Experiment 2. Individually caged rats (CT and TP) were injected (in the
morning of days 27, 28 and 29 of age) s.c. dailywith 1mg
of xenoestrogen [diethylstilbestrol (DES) dissolved in
100 μL of sterile corn oil] to stimulate the development
of early antral follicles. Animals were killed the next
morning (08:00–09:00 h; 30 days of age) and ovaries
were immediately removed for granulosa cell (GC) isola-
tion and culture. Brieﬂy, GCs from DES-treated rats were
isolated by ovary puncture (30-gauge needle) as de-
scribed elsewhere [26] and incubated in Dulbecco Mod-
iﬁed Eagle medium (DMEM, 4.5 g glucose/L)-Ham F12
(1:1, Gibco, Gaithersburg, MD, USA), EGTA (6.8 mM),
and HEPES (10 mM; 15 min at 37 °C), then washed
and incubated in DMEM-F12 (1:1), sucrose (0.5 M),
and HEPES (10 mM; 5 min at 37 °C). After incubation,
the medium was diluted with 2 volumes of DMEM-F12
and HEPES (10 mM), and ovaries were allowed to sedi-
ment. GCs were obtained by pressing ovaries between
two pieces of nylon mesh (Nytex 50, Geneva,
Switzerland). To eliminate contaminating theca/intersti-
tial cells, the crude GC suspension was layered over a
40% Percoll solution in saline solution and centrifuged
at 400×g for 20min. The puriﬁedGC layerwas aspiratedfrom the top of the Percoll solution and resuspended in
DMEM-F12 (1:1) containing sodium bicarbonate
(2.2 g/L; pH: 7.4). Cells were seeded on P12 multiwell
plastic plates (Nunc, Roskilde, Denmark) precoated
with collagen at a density of 3.5 × 105 viable cells per
well. Cells were kept at 37 °C in a 5% CO2 atmosphere.
After 3 h, media were changed to remove nonattached
cells and replaced by fresh media containing antibiotics,
delta-4-androstenedione (10−7 M) and 100 μL of fresh
medium either alone or containing hCG (0.05–0.5 IU/
mL). Cells were then cultured for 48 h. At the end of
this period, media were removed and kept frozen
(−20 °C) until measurement of 17β-estradiol (E2) con-
centrations (see below).
Experiment 3. Vaginal smears of rats from both groups were examined
daily for three consecutive estrous cycles before experi-
mentation [1]. Throughout this time period, samples ob-
tained from TP rats indicated that they had attained
constant estrus. Rats from both groups were then killed
(between 08:00 and 09:00 h) on day 60 of age (adult
age), at proestrous stage (CT) or arrested estrous stage
(TP), in non-fasting condition. Immediately after killing,
trunk blood was collected (into EDTA 10%–sodium ﬂuo-
ride coated plastic tubes) and ovarieswere dissected and
either used for histological analyses or kept frozen (at
−80 °C).
Experiment 4. Vaginal smears of rats from both groups were examined
daily for three consecutive estrous cycles before experi-
mentation. On the morning (07:00–08:00 h) of the ex-
perimental day (age 60–61 days), CT (at the proestrus
stage) and TP (at the arrested estrus stage) rats were
i.v. implanted, under light phenobarbital anesthesia, to
inhibit endogenous LH surge [30], with an indwelling
catheter kept permeable by administering a small vol-
ume (100 μL) of vehicle (10 IU heparin/mL of sterile sa-
line solution, containing 10 mg/mL bovine serum
albumin). After recovery (10:00–11:00 h), rats were i.v.
bled (a small volume, 200 μL) before (sample time
zero) and 1 and 2 h after i.v. injection of 5 mIU/kg hCG
(dissolved in 50 μL of vehicle, see above). Samples
were rapidly centrifuged (at 4 °C, 15 min, 2600 ×g)
and plasma samples kept frozen (−20 °C) until mea-
surement of E2 concentrations.
2.3. Peripheral metabolite measurements
Circulating levels of leptin, insulin, total testosterone and
corticosterone (Cort) were determined by speciﬁc radioimmuno-
assays (RIAs) as described earlier [1]. Plasma concentrations of 17-
hydroxyprogesterone (17OHP4) were determined by a commercial
RIA kit (Immunotech, France). Peripheral concentrations of triglyceride
and glucose were determined by commercial enzymatic-colorimetric
assays (Weiner Lab., Argentina). Finally, plasma and medium concen-
trations of E2 were determined by a speciﬁc RIA published and de-
scribed in detail earlier [1]; the intra-assay coefﬁcient of variation
ranged between 4 and 8%, whereas the inter-assay coefﬁcient of varia-
tion ranged between 9 and 12%.
2.4. Ovarian histology
For histological studies, ﬁve ovaries from each group were removed
and immediately ﬁxed in 4% paraformaldehyde (in 0.2 M pH 7.4 phos-
phate buffer), at 4 °C for a maximum of 3 days. Tissues were then
washed with 0.01 M PBS, immersed in 70% ethanol for 24 h, embedded
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tary microtome. To avoid duplicate analysis of follicles, ﬁve complete
cross sections, 200 μm apart, were stained with hematoxylin–eosin. To
prevent counting the same follicle twice [31], 4-μm step sections were
mounted at 50-μm intervals onto microscope slides by the method de-
scribed by Woodruff et al. [31]. For morphological analysis, sections
were chosen as follows: ﬁve from each end and ﬁve from the middle
of each ovary. Images were analyzed using the Image Pro-Plus 3.0.1 sys-
tem (Media Cybernetics, Silver Spring, MA, USA) as described earlier
[16]. Images at 100× magniﬁcation were digitalized with a Nikon DS-
Fi1-U3 (Nikon, Japan) digital camera mounted on a conventional
Nikon Eclipse 50i light microscope. Follicles were classiﬁed as follows:
primary follicle, with one layer of cuboidal GCs; secondary follicle,
with two or three layers of cuboidal GCs, without antral space; and an-
tral follicle, with three or more layers of cuboidal GCs and one or more
independent antral spaces. Follicles were considered atretic if they
displayed two ormore of the following criteria within a single cross sec-
tion: more than ten pyknotic nuclei, GCs within the antral cavity, GCs
pulling away from the basement membrane, or uneven GC layers [5].
The total number of follicles of ﬁve representative ovarian sections
and the percentage (frequency) of follicles at different developmental
stages were calculated and presented as the mean ± SEM.Table 2
Parameters recorded in juvenile and adult female rats. Data are means± SEM (n= 9 rats
per group). BW: body weight; PMAT: parametrial adipose tissue; AU: arbitrary units.
CT rats TP rats
30 day-old
BW (g) 53.19 ± 1.43 63.15 ± 1.32⁎
PMAT (mg per rat) 79.28 ± 5.74 99.29 ± 5.51⁎
PMAT (mg/100 g BW) 124.31 ± 7.19 150.09 ± 5.75⁎
Triglyceride (g/L) 0.34 ± 0.07 0.31 ± 0.042.5. RNA isolation and real-time quantitative PCR
Total RNA was isolated from the ovaries of rats of both groups by a
modiﬁcation of the single-step, acid guanidinium isothiocyanate–phe-
nol–chloroform extraction method (TRIzol; Invitrogen, Life Tech., USA;
cat. # 15596-026). The yield and quality of RNAextractedwere assessed
by a 260/280 nm optical density ratio and electrophoresis in denaturing
conditions on 2% agarose gel. Total RNA (1 μg) was reverse-transcribed
using random primers (250 ng) and Superscript III Rnase H-Reverse
Transcriptase (200 U/μL Invitrogen, Life Tech, USA; cat # 18989-093).
The primers applied for quantitative real-time PCR analyses are
depicted in Table 1. Two microliters of the reverse transcription mix
was ampliﬁed with the QuantiTect Syber Green PCR kit (Qiagen, cat. #
204143) containing 0.5 μMof each speciﬁc primer using the LightCycler
Detection System (MJ Mini Opticon, Biorad). PCR efﬁciency was near 1.
Threshold cycles (Ct) were measured in separate tubes in duplicate.
Identity and purity of the ampliﬁed product were checked by electro-
phoresis on agarose mini-gels, and the melting curve was analyzed at
the end of ampliﬁcation. Values of the differences between the Ct
were calculated in every sample for each gene of interest as follows:
Ct of the gene of interest − Ct of the reporter gene, β-actin, whose
mRNA levels did not differ between control and test groups, was the re-
porter gene. Relative changes in the expression level of one speciﬁc gene
(ΔΔCt)were calculated as theΔCt of the test groupminus theΔCt of the
CT group, then presented as 2−ΔΔCt.Table 1
Rat speciﬁc primers used for real-time PCR analyses were ACTB: β-actin; P450scc: choles-
terol side-chain cleavage enzyme; P450c17: 17α-hydroxylase/17,20 lyase/17,20
desmolase enzyme; and CPY19: aromatase (se: sense; as: anti-sense; GBAN:GenBankAc-
cession Number; amplicon length, in bp).
GBAN bp
ACTΒ se, 5′-AGCCATGTACGTAGCCATCC-3′ NM_031144 115
as, 5′-ACCCTCATAGATGGGCACAG-3′
P450scc se, 5′-GCGCCGGGCAGCTAGAACTT-3′ NM_017286.2 113
as, 5′-TGGCAGGAGGGGTGGACACG-3′
P450c17 se, 5′-GGCCACGCCTTTCCCTTGGT-3′ NM_012753.2 101
as, 5′-AGCTGGCCAGGGAGGTGCTC-3′
CPY19 se, 5′-CCCGGCTCTCTGGATGGATGC-3′ NM_017085.2 100
as, 5′-TGGCCTCAACCTCACCACGGA-3′2.6. Statistical analysis
Data, expressed asmean±SEM,were analyzed by ANOVA, followed
by post-hoc comparisons with Fisher's test [33]. Morphometric data
were analyzed by the Least Signiﬁcant Difference test for multiple com-
parisons [33]. The nonparametric Mann–Whitney test was used to ana-
lyze data from tissue mRNA expression [33]. P values lower than 0.05
were considered statistically signiﬁcant.
3. Results
3.1. The juvenile rat phenotype
We have previously [15] found that TP rats grow faster than CT rats
after being followed up between 21 (weaning) and 30 days of age. We
now found that 30-day-old TP-treated rats were signiﬁcantly heavier
than CT rats (Table 2). It is important to note that the gain in BW has
taken place despite the lack of differences in food intake (average indi-
vidual amount of food eaten per day between 21 and 30 days of age:
7.66 ± 0.59 and 6.57 ± 0.51 g/day in CT and TP rats, respectively;
n = 9, P N 0.05). Interestingly, PMAT mass was greater in TP than in
CT rats, even after normalizing individual pad mass by the correspond-
ing BW (Table 2). According to a previous ﬁnding [15], the latter differ-
ence correlated well with plasma leptin concentrations, being
signiﬁcantly higher in TP than in CT animals (Table 2). Conversely, plas-
ma concentrations of 17OHP4 were signiﬁcantly lower in TP than in CT
rats (Table 2). Ovary P450scc and CYP19mRNA levels were signiﬁcantly
decreased in TP rats, whereas that of P450c17 remained the same
(Table 2). Finally, no differences between groups were noticed in glu-
cose, insulin and triglyceride peripheral levels (Table 2), nor in those
of (CT and TP values, respectively) testosterone (0.24 ± 0.04 and
0.34 ± 0.06 ng/mL), E2 (29.88 ± 4.75 and 43.48 ± 14.41 pg/mL) and
Cort (14.48 ± 2.49 and 12.38 ± 1.78 μg/dL).
3.2. Glomerulosa cell endocrine function in juvenile, DES-treated rats
A similar number of isolated GCs in culture displayed no group dif-
ferences in spontaneous E2 release into the medium. After incubating
cells with graded hCG concentrations (0.05–0.5 IU/mL), cells developedGlucose (g/L) 1.14 ± 0.05 1.18 ± 0.04
Insulin (ng/mL) 0.56 ± 0.08 0.65 ± 0.04
Leptin (ng/mL) 1.09 ± 0.09 1.79 ± 0.14⁎
17OHP4 (ng/mL) 0.49 ± 0.12 0.18 ± 0.02⁎
Ovary P450scc (AU) 0.99 ± 0.12 0.42 ± 0.09⁎
Ovary P450c17 (AU) 0.98 ± 0.19 0.22 ± 0.07⁎
Ovary CYP19 (AU) 1.01 ± 0.16 0.14 ± 0.04⁎
60 day-old
BW (g) 135.94 ± 2.77 157.14 ± 1.45⁎
PMAT (g per rat) 0.74 ± 0.03 1.09 ± 0.09⁎
PMAT (g/100 g BW) 0.51 ± 0.02 0.69 ± 0.05⁎
Triglyceride (g/L) 0.65 ± 0.09 0.67 ± 0.08
Glucose (g/L) 1.11 ± 0.08 1.21 ± 0.04
Insulin (ng/mL) 0.39 ± 0.05 0.84 ± 0.11⁎
Leptin (ng/mL) 1.32 ± 0.17 2.21 ± 0.11⁎
17OHP4 (ng/mL) 1.51 ± 0.39 0.13 ± 0.02⁎
Ovary P450scc (AU) 1.04 ± 0.19 0.37 ± 0.09⁎
Ovary P450c17 (AU) 1.01 ± 0.19 1.03 ± 0.24
Ovary CYP19 (AU) 1.02 ± 0.21 2.29 ± 0.11⁎
⁎ P b 0.05 vs. CT values.
Fig. 2. Daily recorded body weight from control (CT) and neonatally-androgenized (TP)
rats over development. Values are means ± SEM (n = 12/15 rats per group). *P b 0.05
vs. CT values.
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group examined. Although we observed only a tendency to secrete
more E2 by TP GCs stimulatedwith 0.05 IU/mL hCG, this cell population
did develop a clear hyperresponse to 0.5 IU/mL hCG stimulation (Fig. 1,
upper panel). Indeed, E2 concentrations in the medium were signiﬁ-
cantly (P b 0.05) higher than those in the medium from CT cells.
3.3. Ovarian morphology and follicle counts in juvenile rats
Morphologically, the ovaries from CT rats exhibited follicles in vari-
ous stages of development; in fact, healthy secondary, antral (tertiary)
follicles and corpora lutea were observed. In contrast, the ovaries from
TP rats showed small follicles in early stages of development, in addition
to follicles with evidence of atresia, and antral (tertiary) follicles with a
thickened granulosa layer. Fig. 1 (lower panel) shows that primary and
antral (tertiary) follicle frequencies were 3- and 15-fold higher and
lower, respectively (P b 0.05), in TP than in CT specimens, respectively.
The frequencies of secondary and atretic follicles were similar in the
ovaries from both studied groups.
3.4. The adult rat phenotype
Between 31 and 60 days of age, the growth curve of TP-treated rats
remained displaced to the left of that depicted by CT rats (Fig. 2). Vaginal
opening occurred much earlier (P b 0.05; n = 9 rats per group) in TP
(13.8 ± 1.7 days) than in CT (41.4 ± 0.8 days) rats. As expected, atFig. 1. Upper panel: human Chorionic Gonadotropin (hCG)-stimulated estradiol secretion
by isolated ovarian granulosa cells, obtained from DES-treated, control (CT) and neonatal-
ly-androgenized (TP) juvenile rats. Values aremeans±SEM(n=4different experiments,
6/7 replicates per experiment). a, P b 0.05 vs. respective basal (0 IU hCG/mL) values; b,
P b 0.05 vs. 0.05 IU hCG/mL values in a similar group; c, P b 0.05 vs. CT values in the
same condition. Lower panel: Follicular developmental stage of the ovaries obtained
from control (CT) and neonatally-androgenized (TP) juvenile rats. Values (expressed in
percentages) are means ± SEM (n = 5 animals per group). *P b 0.05 vs. respective CT
values.60 days of age, TP rats were also signiﬁcantly heavier than CT rats
(Table 2), a fact not related to any difference in food intake (average in-
dividual amount of food eaten per day between 31 and 60 days of age:
11.87 ± 0.54 and 11.18 ± 0.57 g/day in CT and TP-treated rats, respec-
tively; n = 9, P N 0.05). Interestingly, PMAT mass was also greater in TP
than in CT rats (Table 2). Similar differenceswere found in plasma leptin
levels, with values signiﬁcantly higher in TP than in CT rats; and plasma
concentrations of 17OHP4 remained signiﬁcantly decreased in TP rats
(Table 2). Regarding mRNA expression levels in the ovary, that of
P450scc remained signiﬁcantly (P b 0.05) lower in TP than in CT rats,
whereas that of P450c17 did not differ among groups; conversely,
CYP19 mRNA concentration was 2-fold higher in TP than in CT rats
(Table 2). Whereas no group-differences were noticed in circulating
levels of glucose and triglyceride, conversely, signiﬁcantly (P b 0.05)
higher plasma insulin values were observed in TP rats (Table 2). Finally,
as occurred in juvenile individuals, no group differences were observed
in circulating levels of (CT and TP values, respectively) testosterone
(0.29 ± 0.05 and 0.31 ± 0.04 ng/mL), E2 (139.43 ± 21.61 and
84.76 ± 18.91 pg/mL) and Cort (9.39 ± 2.02 and 10.51 ± 2.78 μg/dL).
3.5. In vivo E2 secretion throughout an acute i.v. hCG-simulation test
Before testing, we observed that whereas regular estrous cycles
characterized CT rats, TP rats showed cycles arrested at estrus. Thereaf-
ter, 60 day-old rats were subjected to i.v. hCG (5 mIU/kg BW) stimula-
tion of E2 secretion in plasma. Results showed that basal (time zero)
plasma E2 concentrations were similar in both groups and that after
1 h of hCG administration circulating levels of E2 were 2–3-fold higher
(P b 0.05) than the respective basal values in both groups (Fig. 3,
upper panel). Moreover, E2 hyper-secretion was observed in TP rats
after 2 h of hCG i.v. administration (Fig. 3, upper panel).
3.6. Ovarian morphology and follicle counts in adult rats
The ovaries analyzed at 60 days of age indicated that the frequencies
of secondary and atretic stage follicles were 3- and 5-fold lower and
higher (P b 0.05) in TP than in CT rats, respectively (Fig. 3, lower
panel). Conversely, no group differences were noticed in frequencies
Fig. 3.Upper panel: i.v. humanChorionicGonadotropin (hCG)-induced estradiol release in
plasma, in control (CT) and neonatally-androgenized (TP) adult rats. Values are means ±
SEM (n= 7/8 rats per group). a, P b 0.05 vs. respective time zero values; b, P b 0.05 vs. CT
values at the same time. Lower panel: Follicular developmental stage of the ovaries obtain-
ed from control (CT) and neonatally-androgenized (TP) adult rats. Values (expressed in
percentages) are means ± SEM (n = 5 animals per group). *P b 0.05 vs. respective CT
values.
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Whereas ovarian images in CT animals fully correspond with expected
normal characteristics (e.g. antral cavity, corpus luteum, ovocyte, gran-
ulosa cells and internal and external theca cells) (Fig. 4), the ovaries
from TP rats displayed several dysfunctional characteristics. Indeed, im-
ages compatible with a large antral cavity in a cystic follicle bearing de-
creased granulosa and theca (internal and external) cell layers were
observed (Fig. 4). Finally, although images corresponding to corpus
luteumwere observed in the ovaries from CT rats, nonewas seen in tis-
sues from TP animals (data not shown).
4. Discussion
Our results conﬁrm and extend previous data from our laboratories
[1] regarding the metabolic impact of neonatal androgenization in fe-
male rats due to a single TP dose. Indeed, accelerated growth (growth
curve displaced on the left) and consequent heavier bodyweight clearly
characterized TP rats over development. Some features found in our TP
rats are highly indicative of early and clear adipose tissue (AT) dysfunc-
tion, such as enlarged PMAT mass and hyperleptinemia, a phenotype
found at both juvenile and adult stages. We now add a new feature of
this phenotype, namely, overall impaired ovary steroidogenic function
(reduced enzyme gene expression and plasma 17OHP4 levels) and fol-
licular development.
In this TP rat model, we previously [23] found a drastic reduction in
anterior pituitary (AP) LH and FSH contents (namely, at both pre-
pubertal ages, infantile and juvenile) and failure to reach normal high
circulating LH–FSH levels in infancy (15 day-old) age. It must be takeninto account that the lowest AP sensitivity to LHRH in the normal rat oc-
curs at juvenile age [7]. Thus, a relevant mechanism seems to be deeply
altered in these pre-pubertal TP-treated rats: reduced gonadotropin AP
store will in turn soon impair follicle maturation. In agreement with
this, we now found in the ovaries of juvenile (30 day-old) TP-treated
rats more primary and less antral (tertiary) follicles. This clearly indi-
cates impaired follicular maturation, a defect probably dependent on
FSH ovarianhypo-stimulation. In turn, this tissue could develop a partial
reduction in the local machinery (steroidogenic enzymes) for 17OHP4
production. Interestingly, when juvenile follicles were in vivo induced
to mature (DES-treated rats), the corresponding isolated GCs (incubat-
ed in substrate-replete medium) were fully responsive to hCG stimula-
tion, when analyzed in terms of E2 release. In this regard, we must
consider that the ovaries from our intact juvenile TP-treated rats are
rich in primary follicles, although no changes in the atretic follicle pop-
ulation were observed.
Administration of TP to rats on postnatal day 5 did result in a rapid
(12–48 h post-treatment) and transient (only up to 10 days of age) in-
crease in ovarian androgen receptor (AR) expression [6]. Conversely,
ovarian estrogen receptor (ER) expression was ﬁrst (12–48 h post-
treatment) reduced and later (14 days of age) restored to normal in
these rats [6]. In this direction, we previously showed a selective in-
crease in AR but not in ER or progesterone receptor in stroma and gran-
ulosa cells of primordial and primary follicles of ovine (fetal day 90)
ovary at the end of TP treatment. All these data clearly suggest that AR
expression level is a key step in programming adult ovarian dysfunction
[16]. Moreover, increased AR expression in fetal ovaries of prenatal TP-
treated sheep appears to be mediated by androgenic actions of testos-
terone because dihydrotestosterone, a non-aromatizable androgen,
also increases AR expression in primordial/primary follicles from day-
90 fetuses [16]. We must bear in mind that in rodents whole follicular
differentiation is completed in early postnatal life [22], whereas in
sheep this process is fully completed in utero [25]. Also, prenatal testos-
terone excess has been demonstrated to lead to reproductive dysfunc-
tions in sheep with obesity, exaggerating these defects, accelerating
follicular depletion initiated prior to puberty to stockpiling of growing
follicles after puberty, a critical time point in the development of the
PCOS phenotype [18].
Therefore, DNA from rodents is highly susceptible to epigenetic
changes (high methylation) after a transient increase in endogenous
testosterone levels, at either peri-natal or adult ages. These epigenetic
changes have been observed in genes analyzed in the ovaries [34] and
liver [8] from adult individuals and identiﬁed as being involved in key
reproductive and metabolic functions. Moreover, these observations
have served later to sustain the hypothesis that early in life androgen
excess-induced epigenetic DNA modiﬁcations could be involved in the
etiology of the human PCOS phenotype [34].
Upon being in vivo induced to rapid follicle maturation, hCG-
stimulated GCs (from juvenile rats) developed normal E2 secretion.
This observation allows us to postulate that retarded endogenous follic-
ularmaturation (ovarymisprogramming) is a characteristic of our juve-
nile TP rats. However and importantly, follicular ovary ability for
maturation remains unaltered (evident when appropriately stimulated
with the xenoestrogen). These data are highly relevant and clearly in-
dicative of the presence of functional GC LH receptors, probably normal-
ly or over-expressed. The follicular ovary misprogramming observed in
juvenile TP rats persisted up to adulthood. Indeed, ovaries from 60 day-
old TP rats showed reduced frequency of secondary follicles which cor-
related with enhanced frequency of atretic follicles. Moreover, whereas
ovary cystic images were evident, no corpora lutea were found in adult
TP-treated rats. Similar to observations of juveniles, GCs from adult TP-
treated rats were fully in vivo responsive to i.v. hCG stimulation (e.g. E2
secretion). These data further suggest that the low in vivo steroidogenic
activity found in the ovaries from TP rats could depend mainly on an
early defect in AP LH/FSH production and/or secretion (e.g. abnormal
pulsatile pattern of hormone release) [23].
Fig. 4. Representative images of the ovaries from CT (panels A, C and E) and TP (panels B, D and F) adult rats showing ovarian structures at different magniﬁcations: A, B: 10× (bars:
100 μm); C, D: 20× (bars: 50 μm); E, F: 40× (bars: 25 μm). CL: Corpus luteum, IG: interstitial glands; FC: follicular cyst; G: granulosa; TI: theca interna; Ov: ovocyte.
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ries tested the effect of high androgen/estrogen dose administration at
pre- and/or post-natal ages, the present study clearly supports that a
single neonatal (5 day-old) administration of androgen excess is efﬁ-
cient enough to induce a phenotype of female rat highly resembling
that of human PCOS. Indeed, the density of preantral follicles in ovary bi-
opsies from PCOS women was reported to be six-fold higher than in
those from normal women [17,29]. Moreover, PCOS women assisted
for in vitro fertilization and embryo transfer (IVF-ET) displayed high
serum E2 levels post-hCG administration (ovary GC hyperresponse)
and develop a higher number of follicles, thus indicating that PCOS
women are at a moderately high risk of ovarian hyperstimulation syn-
drome (OHSS) [12]. Consequently, the need of prior in vitro follicle mat-
uration in PCOS women before IVF-ET is suggested in order to
signiﬁcantly reduce risk of OHSS. Furthermore, the development of in-
sulin resistance [9] and overweight [10] are clearmetabolic characteris-
tics of the human PCOS phenotype. In this regard, we earlier addressed
[1] that overall AT dysfunction in adult (100 day-old) TP rats includes
high body weight, enlarged PMAT mass and adipocyte size (insulin-re-
sistant cells that release large amounts of leptin), high circulating levels
of leptin and plasminogen activator inhibitor-1 (PAI-1), and reduced
adiponectin plasma concentrations. All these factors are clear
aggravators [1,19,27] of AT and peripheral (as indicated here by theirhigh insulinemia) impaired insulin sensitivity developed by TP rats.
However, whether androgen excess-induced PMAT dysfunction and
hyperleptinemia are responsible for inducing ovary leptin-resistance
and consequently, abnormal folliculogenesis [14] remains to be deter-
mined. The present study found that, in adulthood, this TP rat model
shows dysfunctions similar to those of the PCOS women phenotype,
such as: a) retarded ovary follicle maturation (e.g. large population of
preantral follicles); b) increased body and abdominal adiposityweights;
and c) signs of insulin resistance. Moreover, our experimental data fully
support that abnormal folliculogenesis had clearly beganbefore puberty
and lasted until adulthood. Interestingly, GCs from both juvenile and
adult TP-treated rats retained full endocrine function. It remains to be
determined whether androgen excess-induced epigenetic changes
were installed shortly after TP administration or not, and if so, whether
they are partly or fully responsible for the development of this female
rat phenotype.
5. Conclusion
Our study supports that early in life transient hyperandrogenemia
modiﬁes metabolic and ovary function programming, although ovarian
granulosa cells preserve their endocrine activity. Although the etiology
of human PCOS is not fully understood, our data suggest that girls
72 L. Ongaro et al. / Life Sciences 130 (2015) 66–72with premature adrenarche produce an excess of androgen precursors
that could lead to the development of a PCOS phenotype later in life,
presumably through earlier hyperandrogenemia-induced epigenetic
DNA changes. This condition could impact by misprogramming carbo-
hydrate metabolism (impaired insulin sensitivity, altered glucose toler-
ance and Diabetes Mellitus Type 2) and, as a consequence, PCOS
individuals are highly susceptible to the development of cardiovascular
disease (high PAI-1 production) and reproductive dysfunction (abnor-
mal folliculogenesis); thus resulting in sub-fertility/infertility and/or
poor pregnancy outcome (early miscarriage and/or preeclampsia),
even with high risk of OHSS if pregnancy is sought through IVF-ET.
Therefore, appropriate pharmacological treatment, such as insulin-
sensitizer combined with anti-androgen, should be considered in
these women to restore full metabolic and reproductive functions.
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